Archit Organosys Limited (BOM:524640)
42.44
-1.60 (-3.63%)
At close: Feb 12, 2026
Archit Organosys Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,476 | 1,256 | 1,132 | 1,278 | 1,367 | 945.11 |
Other Revenue | 0.71 | 0.71 | - | - | - | - |
| 1,477 | 1,257 | 1,132 | 1,278 | 1,367 | 945.11 | |
Revenue Growth (YoY) | 30.25% | 11.03% | -11.42% | -6.50% | 44.60% | 23.24% |
Cost of Revenue | 1,032 | 855.16 | 788.21 | 776.99 | 959.52 | 617.16 |
Gross Profit | 445.36 | 401.55 | 343.7 | 500.84 | 407.12 | 327.95 |
Selling, General & Admin | 62.05 | 72.62 | 63.24 | 76.35 | 66.54 | 61.54 |
Other Operating Expenses | 222.53 | 197.79 | 210.06 | 222.45 | 169.36 | 153.28 |
Operating Expenses | 344.41 | 329.84 | 329.89 | 347.6 | 282.76 | 251.47 |
Operating Income | 100.96 | 71.71 | 13.81 | 153.24 | 124.36 | 76.48 |
Interest Expense | -24.34 | -24.76 | -24.59 | -20.92 | -24.45 | -31.66 |
Interest & Investment Income | 26.77 | 26.77 | 14.01 | 3.06 | 10.69 | 4.94 |
Currency Exchange Gain (Loss) | 2.42 | 2.42 | 2.42 | 2.25 | 3.93 | -0.26 |
Other Non Operating Income (Expenses) | 13.74 | 0.48 | -0.62 | -0.66 | 0.47 | -0.35 |
EBT Excluding Unusual Items | 119.55 | 76.62 | 5.03 | 136.96 | 114.99 | 49.15 |
Gain (Loss) on Sale of Investments | -1.35 | -1.35 | 3.19 | 4.45 | - | - |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -1.15 | -6.17 | -4.83 | -2.31 |
Legal Settlements | - | - | -25.05 | - | - | - |
Other Unusual Items | - | - | 59.24 | 18.14 | - | - |
Pretax Income | 118.32 | 75.39 | 43.87 | 153.58 | 114.25 | 46.84 |
Income Tax Expense | 38.04 | 24.88 | 10.49 | 40.09 | 31.94 | -3.22 |
Net Income | 80.27 | 50.51 | 33.38 | 113.49 | 82.32 | 50.07 |
Net Income to Common | 80.27 | 50.51 | 33.38 | 113.49 | 82.32 | 50.07 |
Net Income Growth | 68.61% | 51.33% | -70.59% | 37.87% | 64.42% | - |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 15 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 15 |
Shares Change (YoY) | 0.59% | - | - | - | 36.62% | - |
EPS (Basic) | 3.91 | 2.46 | 1.63 | 5.53 | 4.01 | 3.33 |
EPS (Diluted) | 3.91 | 2.46 | 1.63 | 5.53 | 4.01 | 3.33 |
EPS Growth | 67.55% | 51.24% | -70.59% | 37.87% | 20.46% | - |
Free Cash Flow | - | 180.23 | 85.84 | 12.19 | -2.18 | 79.51 |
Free Cash Flow Per Share | - | 8.78 | 4.18 | 0.59 | -0.11 | 5.29 |
Dividend Per Share | - | 0.500 | - | 0.500 | 0.750 | 0.500 |
Dividend Growth | - | - | - | -33.33% | 50.00% | - |
Gross Margin | 30.15% | 31.95% | 30.36% | 39.20% | 29.79% | 34.70% |
Operating Margin | 6.83% | 5.71% | 1.22% | 11.99% | 9.10% | 8.09% |
Profit Margin | 5.44% | 4.02% | 2.95% | 8.88% | 6.02% | 5.30% |
Free Cash Flow Margin | - | 14.34% | 7.58% | 0.95% | -0.16% | 8.41% |
EBITDA | 160.56 | 129.25 | 68.59 | 195.94 | 164.56 | 107.6 |
EBITDA Margin | 10.87% | 10.29% | 6.06% | 15.33% | 12.04% | 11.38% |
D&A For EBITDA | 59.6 | 57.54 | 54.78 | 42.7 | 40.2 | 31.12 |
EBIT | 100.96 | 71.71 | 13.81 | 153.24 | 124.36 | 76.48 |
EBIT Margin | 6.83% | 5.71% | 1.22% | 11.99% | 9.10% | 8.09% |
Effective Tax Rate | 32.15% | 33.00% | 23.91% | 26.10% | 27.95% | - |
Revenue as Reported | 1,521 | 1,287 | 1,157 | 1,296 | 1,386 | 950.54 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.